Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia

• Adrián Mosquera Orgueira,
• Andrés Peleteiro Raíndo,
• José Ángel Díaz Arias,
• Beatriz Antelo Rodríguez,
• Mónica López Riñón,
• Claudio Cerchione,
• Adolfo de la Fuente Burguera,
• Marta Sonia González Pérez,
• Giovanni Martinelli,
• Pau Montesinos Fernández,
• Manuel Mateo Pérez Encinas

Affiliations

Adrián Mosquera Orgueira

Department of Hematology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain

Andrés Peleteiro Raíndo

Department of Hematology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain

José Ángel Díaz Arias

Department of Hematology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain

Beatriz Antelo Rodríguez

Department of Hematology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain

Mónica López Riñón

Department of Hematology, Tomelloso Hospital, Ciudad Real, Spain

Claudio Cerchione

Unit of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy

Adolfo de la Fuente Burguera

Department of Hematology, MD Anderson Cancer Center, Madrid, Spain

Marta Sonia González Pérez

Department of Hematology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain

Giovanni Martinelli

Unit of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy

Pau Montesinos Fernández

Department of Hematology, Hospital La Fe, Valencia, Spain

Manuel Mateo Pérez Encinas

Department of Hematology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain